[go: up one dir, main page]

AU1735800A - Method of treating seizure disorders - Google Patents

Method of treating seizure disorders

Info

Publication number
AU1735800A
AU1735800A AU17358/00A AU1735800A AU1735800A AU 1735800 A AU1735800 A AU 1735800A AU 17358/00 A AU17358/00 A AU 17358/00A AU 1735800 A AU1735800 A AU 1735800A AU 1735800 A AU1735800 A AU 1735800A
Authority
AU
Australia
Prior art keywords
seizure disorders
treating seizure
treating
disorders
seizure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17358/00A
Inventor
Charles E. Niesen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHARLES E NIESEN
Original Assignee
CHARLES E NIESEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHARLES E NIESEN filed Critical CHARLES E NIESEN
Publication of AU1735800A publication Critical patent/AU1735800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU17358/00A 1998-11-19 1999-11-18 Method of treating seizure disorders Abandoned AU1735800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10905598P 1998-11-19 1998-11-19
US60109055 1998-11-19
PCT/US1999/027384 WO2000028985A1 (en) 1998-11-19 1999-11-18 Method of treating seizure disorders

Publications (1)

Publication Number Publication Date
AU1735800A true AU1735800A (en) 2000-06-05

Family

ID=22325561

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17358/00A Abandoned AU1735800A (en) 1998-11-19 1999-11-18 Method of treating seizure disorders

Country Status (2)

Country Link
AU (1) AU1735800A (en)
WO (1) WO2000028985A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410063B1 (en) 2000-06-13 2002-06-25 Hill's Pet Nutrition, Inc. Composition and method
CN1217001C (en) 2002-01-04 2005-08-31 清华大学 Method of producing D-(-)-3-hydroxy butanoic acid
GB0410266D0 (en) * 2004-05-07 2004-06-09 Ketocytonyx Inc Treatment of apoptosis
US7485743B2 (en) 2004-07-20 2009-02-03 Btg International Limited Oligomeric ketone compounds
FR2997302B1 (en) * 2012-10-29 2015-02-06 Assist Publ Hopitaux De Paris PREVENTION AND TREATMENT OF DEFICITS IN PYRUVATE DESHYDROGENASE
WO2018081118A1 (en) 2016-10-24 2018-05-03 University Of South Florida Delaying latency to seizure by combinations of ketone supplements
US10376528B2 (en) 2017-03-10 2019-08-13 Tecton Group, Llc Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor
US20180303821A1 (en) * 2017-04-24 2018-10-25 BraneQuest, Inc. Membrane active molecules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61502943A (en) * 1984-06-22 1986-12-18 ビ−チ、リチャ−ド・エル Electrolyte solutions and their use in vivo
US5116868A (en) * 1989-05-03 1992-05-26 The Johns Hopkins University Effective ophthalmic irrigation solution
US5330394A (en) * 1991-07-09 1994-07-19 Hydro-Gear Limited Partnership Rider transaxle having improved hydrostatic transmission

Also Published As

Publication number Publication date
WO2000028985A1 (en) 2000-05-25
WO2000028985A9 (en) 2000-11-02

Similar Documents

Publication Publication Date Title
AU6578998A (en) Method of treatment of migraine
AU4880197A (en) Method for treatment of dermatological disorders
AU4868599A (en) Composition for and method of treating neurological disorders
AU3091599A (en) Method of making dimethylnaphtalenes
AU3977700A (en) Method of treating neurological disorders
AU2325999A (en) Methods of neuroendocrine regulation of affective disorders
AU2251897A (en) Method of treating liver disorders
AU5198898A (en) Method for treatment of glutamate related disorders
AU4552200A (en) Method of treating psychotic disorders
AU4636199A (en) Method of reducing or preventing malodour
AU1735800A (en) Method of treating seizure disorders
AU3757300A (en) Method of treating anxiety disorders
AU1133901A (en) Method of treating metabolic disorders
AU2051397A (en) Method of treating alopecia
PL341667A1 (en) Method of treating cooped
AU4525299A (en) Method of reducing or preventing malodour
AUPP508798A0 (en) Method of treating psoriasis
AU1282099A (en) Method for treatment of disorders of attention
AU4027097A (en) Method of treatment
AU5855899A (en) Method for identifying substances for the treatment of c-jun-mediated disorders
AU3753500A (en) Methods of treating fibrinogen-related disorders
AU9119998A (en) Method of time-to-talk calculation
AU2599399A (en) Method of treating migraine
HK1035669A (en) Method of treatment
AUPP193198A0 (en) Method of treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase